[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bot et al., 1997 - Google Patents

Immune response of neonates elicited by somatic transgene vaccination with naked DNA

Bot et al., 1997

View PDF
Document ID
14454272336235646047
Author
Bot A
Antohi S
Bona C
Publication year
Publication venue
Front Biosci

External Links

Snippet

Introduction 3. Immune responsiveness of the neonatal B cells 3.1. Humoral responses of mice immunized as neonates with naked DNA 4. Immune responsiveness of the neonatal T cells 4.1. Quantitative differences between the immune systems of neonates and adults 4.2 …
Continue reading at article.imrpress.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Bot et al. Immune response of neonates elicited by somatic transgene vaccination with naked DNA
CN110191898B (en) CD33 specific chimeric antigen receptor
Ahlers et al. Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines
Wang et al. Multiple paths for activation of naive CD8+ T cells: CD4-independent help
US8895020B2 (en) Single chain trimers and uses therefor
US8518697B2 (en) Single chain trimers and uses therefor
US20080311140A1 (en) Antigen specific immunosuppression by dendritic cell therapy
RU2724994C2 (en) Modified epitopes for amplifying responses of cd4+ t-cells
JPH10503379A (en) MHC complex and use thereof
EP3920939B1 (en) Chimeric antigen receptor-modified cells for the treatment of cldn6-expressing cancers
CN110857319B (en) Isolated T cell receptor, modified cell, encoding nucleic acid and application thereof
JP2001508430A (en) Compounds, compositions and methods for endocytic presentation of immunosuppressive factors
JP2024059867A (en) Compositions and methods of phospholipase a2 receptor chimeric autoantibody receptor t cells
JP7561036B2 (en) Compositions and methods for muscle-specific kinase chimeric autoreceptor cells - Patents.com
NO327411B1 (en) Polynucleotide encoding a chimeric CD40 ligand.
US20110008332A1 (en) Combination Therapy to Treat Persistent Viral Infections
US20130183347A1 (en) Somatic Transgene Immunization and Related Methods
JP2021503276A (en) Regulatory T cell epitope
Jones et al. CD4 effector TCR avidity for peptide on APC determines the level of memory generated
US20080076175A1 (en) Somatic transgene immunization and related methods
US7011833B1 (en) Enhancing immune responses with B7-1 or B7-2 in the absence of a crosslinking agent
ES2352745T3 (en) FELINO CD86.
JP5854604B2 (en) Ig-pConsensus gene vaccination protects against antibody-dependent immune pathology in autoimmune diseases
WO2001015728A1 (en) Method for activating cytotoxic t-lymphocytes (ctls) in vivo : composition comprising antibody anti cd40 (or cd40l or cd40 binding protein) and an antigen
Bennink et al. Multiple Paths for Activation of Naive CD8